Van Jones’ We Rise Against Hate Tour comes to Dallas as part of a 14-city tour that aims to address the current divisive climate in American and engage local communities and changemakers to help address some of the most pressing issues facing America, including social justice, racism, equality, climate justice, criminal justice reform and equal access to opportunities in tech. 100 percent of net ticket proceeds will go to Van Jones’ nonprofit, the Dream Corps, its initiatives, and local partner charities.
Participants will include Van Jones, CNN commentator and president of Dream Corps, and Mark Cuban, businessman, investor, author, television personality, and philanthropist.
Van Jones’ We Rise Against Hate Tour comes to Dallas as part of a 14-city tour that aims to address the current divisive climate in American and engage local communities and changemakers to help address some of the most pressing issues facing America, including social justice, racism, equality, climate justice, criminal justice reform and equal access to opportunities in tech. 100 percent of net ticket proceeds will go to Van Jones’ nonprofit, the Dream Corps, its initiatives, and local partner charities.
Participants will include Van Jones, CNN commentator and president of Dream Corps, and Mark Cuban, businessman, investor, author, television personality, and philanthropist.
Van Jones’ We Rise Against Hate Tour comes to Dallas as part of a 14-city tour that aims to address the current divisive climate in American and engage local communities and changemakers to help address some of the most pressing issues facing America, including social justice, racism, equality, climate justice, criminal justice reform and equal access to opportunities in tech. 100 percent of net ticket proceeds will go to Van Jones’ nonprofit, the Dream Corps, its initiatives, and local partner charities.
Participants will include Van Jones, CNN commentator and president of Dream Corps, and Mark Cuban, businessman, investor, author, television personality, and philanthropist.